Physiological Concentrations of Cholecystokinin Stimulate Amino Acid-Induced Insulin Release in Humans*
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
After a meal, hormones released from the gut potentiate insulin release. This study was undertaken to determine if physiological concentrations of plasma cholecystokinin (CCK) stimulate insulin secretion in man. Employing a specific CCK bioassay, postprandial CCK levels were determined in normal subjects. Ingestion of a mixed liquid meal stimulated an increase in circulating CCK from a mean fasting level of 0.9 +/- 0.2 (SEM) pmol/L to a mean peak level of 7.1 +/- 1.1 pmol/L within 10 min of feeding. After 30 min the mean CCK level fell to 3.5 pmol/L and remained elevated for the remainder of the 90-min experiment. Eight subjects underwent 40-min infusions of either arginine (15 g), mixed amino acids (15 g), or glucose (30 g) with or without the simultaneous infusion of CCK-8. Since CCK-8 has full biological potency, this form was chosen for infusion to reproduce total CCK bioactivity in plasma. CCK-8 was infused at rates of 12 or 24 pmol/kg X h, producing steady state plasma CCK levels of 4.5 +/- 0.7 and 8.2 +/- 1.1 pmol/L, respectively, spanning the range of normal postprandial levels. CCK alone had no effect on insulin, glucose, or glucagon levels. Administration of arginine alone stimulated insulin from a mean basal level of 12.8 +/- 1.3 microU/mL to a peak level of 41.3 +/- 5.4 microU/mL. Infusion of CCK at 12 and 24 pmol/kg X h augmented arginine-stimulated insulin levels to peaks of 62.5 +/- 13.9 and 63.0 +/- 4.0 microU/mL, respectively. Moreover, CCK nearly doubled the total amount of insulin secreted during the arginine infusion. A similar potentiation of glucagon release was found with both doses of CCK. In addition, infusion of a mixture of amino acids with and without concomitant CCK infusions revealed that CCK potentiated the insulin release induced by mixed amino acids. In contrast to the potent effect of CCK on amino acid-induced insulin release, infusions of CCK together with glucose caused no enhancement of glucose-stimulated insulin release. These results demonstrate that physiological concentrations of CCK potentiate amino acid (but not glucose)-induced insulin secretion in man. These data suggest, therefore, that CCK may have a role in man as a modulator of insulin release.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CCK, which is synthesized and released from duodenal I-cells, potentiates basal, glucose-236, 237 and amino acid-induced insulin secretion,238 and augments glucagon secretion.237, 239”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [238]
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,199
STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN. 1
Dupre, J., Ross, S. A., Watson, D., & Brown, J. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-826 · Cited by 860
Studies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837
Liddle, R. A., Goldfine, I. D., Rosen, M. S., Taplitz, R. A., & Williams, J. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111809 · Cited by 745
Self-citationStimulation of insulin secretion by amino acids.
Floyd, J. C., Fajans, S. S., Conn, J. W., Knopf, R. F., & Rull, J. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105456 · Cited by 727
Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhibitor, and alcohol
Liddle, R. A., Goldfine, I. D., & Williams, J. A. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90524-9 · Cited by 410
Self-citationBondar, R. J. L., & Mead, D. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.5.586 · Cited by 357
Unger, R. H., Ketterer, H., Dupré, J., & Eisentraut, A. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105565 · Cited by 337
Bantle, J. P., Laine, D. C., Castle, G. W., Thomas, J. W., Hoogwerf, B. J., & Goetz, F. C. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307073090102 · Cited by 306
New developments in the incretin concept
Creutzfeldt, W., & Ebert, R. (1985) · Diabetologia · doi:10.1007/bf00281990 · Cited by 279
Inhibition of Gastric Emptying is a Physiological Action of Cholecystokinin
Debas, H. T., Farooq, O., & Grossman, M. I. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80236-8 · Cited by 277
Regulation of gastric emptying in humans by cholecystokinin.
Liddle, R. A., Morita, E. T., Conrad, C. K., & Williams, J. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112401 · Cited by 274
Self-citationGo, V. L. W., Hofmann, A. F., & Summerskill, W. H. J. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106373 · Cited by 247
PATTERNS OF HORMONAL RELEASE AFTER GLUCOSE, PROTEIN, AND GLUCOSE PLUS PROTEIN
Rabinowitz, D., Merimee, T. J., Maffezzoli, R., & Burgess, J. A. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92767-x · Cited by 246
Dupre, J., Curtis, J. D., Unger, R. H., Waddell, R. W., & Beck, J. C. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106032 · Cited by 190
Ipp, E., Dobbs, R. E., Arimura, A., Vale, W., Harris, V, & Unger, R. H. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108829 · Cited by 163
Release of Cholecystokinin in Man
WIENER, I., Inoue, K., Fagan, C. J., Lilja, P., Watson, L. C., & Thompson, J. C. (1981) · Annals of Surgery · doi:10.1097/00000658-198109000-00010 · Cited by 154
CHOLECYSTOKININ: A HORMONE AND A NEUROTRANSMITTER
Williams, J. A. (1982) · Biomedical Research · doi:10.2220/biomedres.3.107 · Cited by 130
Beglinger, C., Fried, M., Whitehouse, I., Jansen, J. B. �. �., Lamers, C. B. H. W., & Gyr, K. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111850 · Cited by 128
Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus.
Yamagishi, T., & Debas, H. T. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.234.4.e375 · Cited by 117
Verspohl, E. J., Ammon, H. P. T., Williams, J. A., & Goldfine, I. D. (1986) · Diabetes · doi:10.2337/diab.35.1.38 · Cited by 108
Self-citationSZECóWKA, J., LINS, P. E., & EFENDIĆ, S. (1982) · Endocrinology · doi:10.1210/endo-110-4-1268 · Cited by 83
Otsuki, M., Sakamoto, C., Hosai, Y., Maeda, M., Morita, S., Ohki, A., Kobayashi, N., Terashi, K., Okano, K., & Baba, S. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109325 · Cited by 75
Sakamoto, C., Goldfine, I. D., Roach, E., & Williams, J. A. (1985) · Diabetes · doi:10.2337/diab.34.4.390 · Cited by 74
Self-citationHERMANSEN, K. (1984) · Endocrinology · doi:10.1210/endo-114-5-1770 · Cited by 73
Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33
Solomon, T. E., Yamada, T., ELASHOFF, J. D., Wood, J., & Beglinger, C. (1984) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1984.247.1.g105 · Cited by 62
Effects of the Octapeptide of Cholecystokinin on Insulin and Glucagon Secretion in the Dog
Frame, C., Davidson, M. B., & Sturdevant, R. A. L. (1975) · Endocrinology · doi:10.1210/endo-97-3-549 · Cited by 61
Cholecystokinin and gallbladder contraction: Effect of CCK infusion
Byrnes, D. J., Borody, T. J., Daskalopoulos, G., Boyle, M., & Benn, I. (1981) · Peptides · doi:10.1016/0196-9781(81)90041-3 · Cited by 54
The control of pancreatic secretion.
Harper, A. A. (1972) · Gut · doi:10.1136/gut.13.4.308 · Cited by 46
Tasaka, Y., Sekine, M., Wakatsuki, M., Ohgawara, H., & Shizume, K. (1975) · Hormone and Metabolic Research · doi:10.1055/s-0028-1093738 · Cited by 43
Raptis, S. A., Dollinger, H. C., Schröder, K. E., Schleyer, M., Rothenbuchner, G., & Pfeiffer, E. F. (1973) · New England Journal of Medicine · doi:10.1056/nejm197306072882302 · Cited by 42
Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini
Liddle, R. A., ELASHOFF, J. D., & Reeve, J. R. (1986) · Peptides · doi:10.1016/0196-9781(86)90085-9 · Cited by 29
Self-citationGlucagon Stimulation of Insulin Release in Man: Inhibition during Hypoglycemia
GOLDFINE, I. D., CERASI, E., & LUFT, R. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-2-312 · Cited by 24
Self-citationEndogenous opioids modulate the effect of cholecystokinin on insulin release in dogs
Schusdziarra, V., Lenz, N., Rewes, B., & Pfeiffer, E. F. (1984) · Neuropeptides · doi:10.1016/0143-4179(84)90094-5 · Cited by 10
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Biological actions of cholecystokinin
Crawley, J. N., & Corwin, R. L. (1994) · Peptides · doi:10.1016/0196-9781(94)90104-x · Cited by 712
Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
The Cells of the Islets of Langerhans
Da Silva Xavier, G. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030054 · Cited by 295
Metadata
- Authors
- RUSHAKOFF, R. J., GOLDFINE, I. D., CARTER, J. D., & LIDDLE, R. A.
- Affiliations
- University of California, San Francisco (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1987-09
- Volume
- 65
- Issue
- 3
- Pages
- 395-401
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1978790290
- Cited by
- 96
- References
- 34
- Citations by year
- 2025: 6 · 2024: 1 · 2022: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 5 · 2014: 3 · 2012: 1
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AM-07997-11)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 01291, DK-32994)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- cholecystokinin, insulin secretion, CCK-8, L-arginine, glucagon secretion, glucose-stimulated insulin secretion, gastrointestinal hormones, incretin effect, plasma CCK levels, glucose infusion, glucagon infusion, CCK receptor antagonists
- MeSH terms
- Insulin Secretion, Adult, Amino Acids, Arginine, Cholecystokinin, Drug Synergism, Glucagon, Glucose, Humans, Insulin, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.